Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZK7IT)

Drug Name
BCT-100 Drug Info
Synonyms RhArg-peg; Pegylated recombinant human arginase (cancer), BCT
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMZK7IT

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Arginase (ARG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
INCB01158 DM8124R Solid tumour/cancer 2A00-2F9Z Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Arginase (ARG) TTSANDR ARGI1_HUMAN; ARGI2_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT01092091) Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002). U.S. National Institutes of Health.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)